Insider filing · DXCM
Kevin R Sayer
Executive Chair
profile →
DexCom, Inc.
DXCM · Healthcare · 49 filings in 24 months
ticker →
Kevin R Sayer sold $2.3M of DexCom (DXCM)
Executed Mar 12 2025, disclosed Mar 14 2025, 2 days later.
Value, as filed
$2.3M
32,498 sh × $70.38
Executed
Mar 12 2025
the trade date, as filed
Disclosed
Mar 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KSKevin R Sayer (Executive Chair) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in DexCom, Inc. (DXCM). The largest single filing was $2.4M of DXCM (26,659 sh across 2 lots, as filed), executed Aug 20.
The name
DXCMHealthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kevin R Sayer in DXCM
DXCMSALE
DexCom, Inc.
$2.4M26,659 sh across 2 lots
Exec Aug 20
Filed Aug 24 · 4:01 PM ET DXCMSALE DexCom, Inc. $2.0M
26,756 sh × $76.32
Exec Jul 20
Filed Jul 21 · 4:58 PM ET DXCMSALE DexCom, Inc. $1.9M
26,756 sh × $72.00
Exec Jul 6
Filed Jul 7 · 4:09 PM ET DXCMSALE DexCom, Inc. $1.9M
26,759 sh × $72.00
Exec May 21
Filed May 26 · 5:30 PM ET DXCMSALE DexCom, Inc. $2.9M
33,359 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET